Effect of acupuncture on clinical outcomes of IVF-ET in patients with repeated implantation failure: a multicenter randomized controlled trial

Obstetrics and Gynecology Hospital of Fudan University0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Meet any of the following:
•1) More than 3 times of embryo transfer failed, and at least 4 high-quality embryos were transferred;
•2) Two consecutive embryo transfer failures, and at least 4 high quality embryos were transferred.
•2. IVF / ICSI / PGD for embryo transfer;
•3. 1-2 high-quality embryos at D3 cleavage stage or blastocysts will be transffered for IVF or ICSI, and only one blastocyst will be transferred from PGD;
•4. Aged 20-38 years;
•5. Sign informed consent voluntarily.

•1. Those who have contraindications to pregnancy or assisted reproductive technology;
•2. Chromosomal abnormalities of either spouse (except polymorphism);
•3. Abnormal gene diseases via PGD examination;
•4. Untreated uterine diseases (uterine malformation, submucous myoma, adenomyosis, endometriosis, etc.) which affect the shape of uterine cavity;
•5. AMH < 1.1ng/ml or AFC < 7;
•6. The endometrial thickness on the day of transformation/ovulation less than 7 mm;
•7. More than 2 times of clinical pregnancy abortion;
•8. Patients with serious primary diseases in cardiovascular, liver, kidney, and hematopoietic system, or with mental diseases;
•9. Those who have been given treatment (such as acupuncture and Traditional Chinese Medicine) related to regulating menstruation and helping pregnancy in the lateset 3 months.

发起方

Obstetrics and Gynecology Hospital of Fudan University